Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency - Wikidata - awgldk - TriplyDB

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

http://www.wikidata.org/entity/Q34454454

about

Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology Correction of canine X-linked severe combined immunodeficiency by in vivo retroviral gene therapy Advances of gene therapy for primary immunodeficiencies Clinical development of gene therapy: results and lessons from recent successes Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models Retroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectives Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy Severe combined immunodeficiencies (SCID)Adenosine deaminase: functional implications and different classes of inhibitors.Concise review: lessons learned from clinical trials of gene therapy in monogenic immunodeficiency diseases.Gene therapy for ADA-SCID, the first marketing approval of an ex vivo gene therapy in Europe: paving the road for the next generation of advanced therapy medicinal products.Development of improved adenosine deaminase retroviral vectors.High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.Single Cell-Based Vector Tracing in Patients with ADA-SCID Treated with Stem Cell Gene Therapy.Gene therapy of genetic diseases and cancer.Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.Adenosine deaminase deficiency as the first target disorder in gene therapy.Stem cell therapy in utero.HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.Current status of retroviral vector mediated gene transfer into human hematopoietic stem cells.Evaluation of Quality Parameters for Cord Blood Donations.Hematopoietic stem cells can be CD34+ or CD34-.Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases.Bone marrow transplant for sickle cell disease--an update Contributions of gene marking to cell and gene therapies.Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors Hematopoietic stem cell gene therapy: progress toward therapeutic targets.HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death.Human artificial chromosomes for gene delivery and the development of animal models Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results.Gene therapy for cystic fibrosis: challenges and future directions Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes.In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors.Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors.High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells.Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys.Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice.Delivery systems and molecular targets of mechanism-based therapies for GBM.

P2860

Q24595921-3585C256-39C9-4829-B6C6-1A65C841450D Q24685725-D39B0939-4D29-4CDA-8892-AB8446844FA8 Q26742031-38EE14AC-0121-43B0-84A8-15D4A8CA9A27 Q26743393-D4687F0B-17D9-4127-9471-9F72D9F927D1 Q26859147-F3B60D75-FFF1-4729-885B-1A406F74EFAE Q28074002-EBFC6461-9A79-4000-898E-5F764375E84D Q28298655-A91006FF-50B8-49D3-B960-A7471B5487E7 Q29042256-1DB205BE-2221-4499-9AF7-B179DC2CE0D1 Q32063453-52AE4328-30A2-456A-A1D2-2B42274CCB29 Q33552027-F6FE127B-E3BB-40FD-BBBC-A1A56C03FA01 Q33749021-CFDF1EFE-8427-4E08-B601-46ACE2034074 Q33782258-10E89567-B0E6-4E2A-AAF3-F4B01353111E Q33784122-8958C7FC-F256-4525-A666-834252F11223 Q33784306-9DEE1609-9D43-4C7D-B21C-F8C7D7FF2B98 Q33788236-9A780972-0813-46B9-95BD-5B771DF68614 Q33804205-9184E8B3-D414-444E-9EED-9D7A3C0ABFD8 Q34074759-EFA21F01-8539-487F-86DA-11EC5F64E017 Q34110702-72DEBE5D-8B87-4FF8-83DC-D65AED8895B0 Q34204696-CBEF71D9-272A-4FE8-A54D-8428F8DE5E9B Q34244510-B887B04D-0E21-479C-B132-6C53F55FFCBA Q34263554-4DC13705-DADF-4B8D-BAB0-127BD54F7318 Q34293470-C33DACDD-C3AB-4036-BDBC-DEB38351110F Q34401676-D4D36244-1968-4C0F-90B1-D08BA8055972 Q34799417-D4D713FE-2957-4770-ABE5-11C41C2BEEE0 Q35059829-2DEB6235-E7D6-4BBF-9FB7-572E0FA0EC6B Q35064224-DFC346DF-E3BE-427E-99B5-2672F219A315 Q35158023-9B218CB6-CD31-40CD-8F38-5AD08A7B02D3 Q35159818-B25690AD-16C1-4904-B91D-F87EE4B9991E Q35238272-1B006836-EDD8-4AA4-BCCA-11674764752B Q35674530-C95D33A1-6438-463F-B142-74A93556AB0F Q35767578-2DE597C6-7721-4B51-96D7-172769AC92CB Q35800195-E9654EF0-5029-43FD-A011-D5ECEBC0EDCE Q35847830-7E8132A9-0923-4790-9344-1EDF2568CE55 Q35848397-C11BC7A8-A572-4F98-9995-74978684EE62 Q35863619-A35E0352-FBFC-4B59-AB69-567760B5D13C Q35869915-25A37C4A-6F9E-4EAA-BB3E-67AF362E171D Q35877342-37FBD93A-7FB7-4A21-9150-89D43B826705 Q35939500-686607A0-199F-4F1B-A268-FAEC5598C3C8 Q35995307-1061CDFD-4087-4456-9F92-F5AD641A52E0 Q36107160-3FDC4D91-D0A3-4F97-8FE4-120C598ED965

P2860

Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency

http://www.wikidata.org/entity/Q34454454

description

1995 nî lūn-bûn

@nan

1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@ast

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@en

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@nl

type

label

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@ast

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@en

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@nl

prefLabel

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@ast

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@en

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@nl

P1433

Q34454454-6A7D0751-7025-4EE1-A336-3B95E2BA86FC

P1476

Q34454454-8061D38D-685B-4B29-AE23-56AA7767817F

P2093

Q34454454-0260A184-2BFF-4D82-82B0-4EE64D539BB4

Q34454454-188BC49C-E277-407A-8D80-D02B43DA0D0A

Q34454454-4AE15321-4178-4532-8CAE-8884AAD77B91

Q34454454-B5DD4104-29D2-47C3-A36C-E0A35CCE3504

Q34454454-C9B7EA48-A60E-4483-B9F9-639FDA310BC7

Q34454454-CC57C74C-0D16-432D-9829-FF9D4C99DECC

Q34454454-D8A94A6E-EB6B-47BE-8BF1-446D336933CD

Q34454454-E4C921AC-9E43-4FD1-AA52-A5AEDD302EA2

P2860

Q34454454-0B8F8561-6906-4324-8443-4A59F7C38D86

Q34454454-105598A1-7619-4ACE-A370-066FF792B9DE

Q34454454-11518879-EBDB-4D63-AB4B-A5D3D66DAE0A

Q34454454-161E15A6-3E9C-4EC8-A11D-9E5027B388E4

Q34454454-1AC49B62-0838-4180-957F-38DFD9F158C4

Q34454454-3772A603-29CA-468F-9727-3298A8DD7993

Q34454454-3ED87FA2-B0D0-4157-B408-CDD7BABD3DE9

Q34454454-45D70AA3-443C-4FF2-B0E1-3B287ED8DF27

Q34454454-4CFCC5B9-B899-48B4-A6EF-C53BDBB68AE9

Q34454454-5BF485DF-A871-4B9B-A99A-F63EBF3A4CBC

P2888

Q34454454-08652E37-B4D7-4A35-BCCC-12ADFA576E4D

P304

Q34454454-4AA1FD55-6535-4939-A6AA-888763D70471

P31

Q34454454-EDC6F5B6-6AC4-4C9F-8764-21B88BA26F04

P356

Q34454454-EFBA895B-5770-4FCF-86FA-CDC2EFE2FF24

P407

Q34454454-44F57F63-46A3-4682-AC25-F5241EC015B8

P433

Q34454454-AABAB46A-4FB5-4CD7-BAC1-02E1424A4D5F

P478

Q34454454-9E54CEB7-CF60-46C1-A84D-CC34C517CD39

P50

Q34454454-1F2B8699-089E-4989-A5D8-8660447B6D30

Q34454454-7EF62A0C-F887-47A9-B95C-E085609425A9

P577

Q34454454-DB66A0C1-FD8D-4F91-98E8-42BAC472E1C0

P5875

Q34454454-2BDDEC6E-92EA-48D9-9B8D-08D9BAA8C7C2

P698

Q34454454-8C9D1BB6-F5CC-46F7-8061-D1DFA63617CB

P932

Q34454454-6D7D1F0B-B192-4322-9E51-6409BA1AE8A4

P356

P1433

Nature Medicine

P1476

Engraftment of gene-modified u ...... adenosine deaminase deficiency

@en

P2093

A el-Khoureiy

http://www.w3.org/2001/XMLSchema#string

C Lenarsky

http://www.w3.org/2001/XMLSchema#string

G Annett

http://www.w3.org/2001/XMLSchema#string

G M Crooks

http://www.w3.org/2001/XMLSchema#string

J S Brooks

http://www.w3.org/2001/XMLSchema#string

K I Weinberg

http://www.w3.org/2001/XMLSchema#string

L N Heiss

http://www.w3.org/2001/XMLSchema#string

M E Hanley

http://www.w3.org/2001/XMLSchema#string

P2860

Severe combined immunodeficiency due to a specific defect in the production of interleukin-2

Genetic applications of an inverse polymerase chain reaction

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells

Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice.

Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency

Human umbilical cord blood as a source of transplantable hematopoietic stem and progenitor cells.

Retroviral-mediated transfer of the human glucocerebrosidase gene into cultured Gaucher bone marrow.

A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences.

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

P2888

P304

1017-1023

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1095-1017

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15710457

http://www.w3.org/2001/XMLSchema#string

P698

7489356

http://www.w3.org/2001/XMLSchema#string

P932

3013367

http://www.w3.org/2001/XMLSchema#string